Zentalis Pharmaceuticals, Inc. - COM (ZNTL)

Q3 2022 13F Holders as of 9/30/2022

Type / Class
Equity / COM
Number of holders
115
Total Shares
58.8M
Shares change
-1.74M
Total reported value, excl. options
$1.27B
Value change
-$54.1M
Put/Call ratio
0
Number of buys
64
Number of sells
-52
Price
$21.66
Investor Option Weight % Change % Value $ * Price $ Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.